Cardiovascular disease: risk assessment and reduction, including lipid modification

Recommendation ID: CG181/4
Question: What is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes?
Any explanatory notes (if applicable): People with type 1 diabetes have increased CVD risk derived from age, sex, glycaemia, blood pressure, renal function and lipid levels as identified in epidemiological studies. Long-term glycaemic control is associated with better outcomes but no trial has investigated the efficacy of statin therapy or other LDL-cholesterol-lowering therapies exclusively in people with type 1 diabetes.

Source guidance details

Comes from guidance: Cardiovascular disease: risk assessment and reduction, including lipid modification
Number: CG181
Date issued: July 2014

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	07/10/2014